nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenprocoumon—ALB—Fluorouracil—urinary bladder cancer	0.162	0.186	CbGbCtD
Phenprocoumon—CYP3A4—Thiotepa—urinary bladder cancer	0.157	0.18	CbGbCtD
Phenprocoumon—CYP2C8—Fluorouracil—urinary bladder cancer	0.125	0.144	CbGbCtD
Phenprocoumon—CYP2C8—Etoposide—urinary bladder cancer	0.105	0.12	CbGbCtD
Phenprocoumon—ALB—Methotrexate—urinary bladder cancer	0.0895	0.103	CbGbCtD
Phenprocoumon—CYP2C9—Fluorouracil—urinary bladder cancer	0.0875	0.1	CbGbCtD
Phenprocoumon—CYP2C9—Cisplatin—urinary bladder cancer	0.0743	0.0853	CbGbCtD
Phenprocoumon—CYP3A4—Etoposide—urinary bladder cancer	0.0425	0.0487	CbGbCtD
Phenprocoumon—CYP3A4—Doxorubicin—urinary bladder cancer	0.029	0.0332	CbGbCtD
Phenprocoumon—VKORC1—prostate gland—urinary bladder cancer	0.0104	0.162	CbGeAlD
Phenprocoumon—Dicoumarol—NQO1—urinary bladder cancer	0.00934	0.472	CrCbGaD
Phenprocoumon—CYP2C9—urine—urinary bladder cancer	0.00855	0.134	CbGeAlD
Phenprocoumon—VKORC1—renal system—urinary bladder cancer	0.00707	0.11	CbGeAlD
Phenprocoumon—CYP3A4—urine—urinary bladder cancer	0.00652	0.102	CbGeAlD
Phenprocoumon—VKORC1—female reproductive system—urinary bladder cancer	0.00566	0.0884	CbGeAlD
Phenprocoumon—ORM1—prostate gland—urinary bladder cancer	0.00561	0.0876	CbGeAlD
Phenprocoumon—Benzphetamine—POR—urinary bladder cancer	0.00437	0.221	CrCbGaD
Phenprocoumon—VKORC1—lymph node—urinary bladder cancer	0.00331	0.0517	CbGeAlD
Phenprocoumon—ORM1—female reproductive system—urinary bladder cancer	0.00306	0.0478	CbGeAlD
Phenprocoumon—CYP2C8—renal system—urinary bladder cancer	0.00236	0.0368	CbGeAlD
Phenprocoumon—Ketoprofen—CXCL8—urinary bladder cancer	0.00219	0.111	CrCbGaD
Phenprocoumon—CYP2C8—female reproductive system—urinary bladder cancer	0.00189	0.0295	CbGeAlD
Phenprocoumon—ORM1—lymph node—urinary bladder cancer	0.00179	0.028	CbGeAlD
Phenprocoumon—CYP2C8—vagina—urinary bladder cancer	0.00171	0.0267	CbGeAlD
Phenprocoumon—CYP2C9—female reproductive system—urinary bladder cancer	0.00168	0.0262	CbGeAlD
Phenprocoumon—CYP3A4—renal system—urinary bladder cancer	0.0016	0.0249	CbGeAlD
Phenprocoumon—ALB—lymph node—urinary bladder cancer	0.00157	0.0245	CbGeAlD
Phenprocoumon—Oxaprozin—PTGS2—urinary bladder cancer	0.00131	0.0661	CrCbGaD
Phenprocoumon—CYP3A4—female reproductive system—urinary bladder cancer	0.00128	0.02	CbGeAlD
Phenprocoumon—Fenoprofen—PTGS2—urinary bladder cancer	0.00108	0.0546	CrCbGaD
Phenprocoumon—Phenylbutazone—PTGS2—urinary bladder cancer	0.000865	0.0437	CrCbGaD
Phenprocoumon—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000676	0.0152	CbGpPWpGaD
Phenprocoumon—CYP2C9—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000647	0.0146	CbGpPWpGaD
Phenprocoumon—Ketoprofen—PTGS2—urinary bladder cancer	0.000639	0.0322	CrCbGaD
Phenprocoumon—ALB—Folate Metabolism—SLC19A1—urinary bladder cancer	0.000598	0.0135	CbGpPWpGaD
Phenprocoumon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000581	0.0131	CbGpPWpGaD
Phenprocoumon—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00056	0.0126	CbGpPWpGaD
Phenprocoumon—CYP2C8—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000557	0.0125	CbGpPWpGaD
Phenprocoumon—CYP2C9—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000552	0.0124	CbGpPWpGaD
Phenprocoumon—VKORC1—Metabolism of proteins—CDX2—urinary bladder cancer	0.000531	0.0119	CbGpPWpGaD
Phenprocoumon—CYP2C9—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000454	0.0102	CbGpPWpGaD
Phenprocoumon—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000452	0.0102	CbGpPWpGaD
Phenprocoumon—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.000424	0.00954	CbGpPWpGaD
Phenprocoumon—CYP2C8—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000423	0.00953	CbGpPWpGaD
Phenprocoumon—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000415	0.00933	CbGpPWpGaD
Phenprocoumon—ALB—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.000409	0.00921	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—GSTZ1—urinary bladder cancer	0.000379	0.00854	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000374	0.00842	CbGpPWpGaD
Phenprocoumon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000369	0.00831	CbGpPWpGaD
Phenprocoumon—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000364	0.0082	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—GSTO2—urinary bladder cancer	0.00036	0.0081	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—NAT1—urinary bladder cancer	0.00036	0.0081	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000355	0.00798	CbGpPWpGaD
Phenprocoumon—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000344	0.00775	CbGpPWpGaD
Phenprocoumon—VKORC1—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000333	0.0075	CbGpPWpGaD
Phenprocoumon—ALB—Folate Metabolism—MPO—urinary bladder cancer	0.000333	0.00749	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—UGT2B7—urinary bladder cancer	0.000329	0.0074	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000324	0.0073	CbGpPWpGaD
Phenprocoumon—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000318	0.00715	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	0.000309	0.00695	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000304	0.00685	CbGpPWpGaD
Phenprocoumon—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000299	0.00674	CbGpPWpGaD
Phenprocoumon—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000298	0.00671	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—CYP4B1—urinary bladder cancer	0.000296	0.00667	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.000293	0.00659	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.000293	0.00659	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000292	0.00657	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000289	0.0065	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.000268	0.00603	CbGpPWpGaD
Phenprocoumon—ALB—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000264	0.00595	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000264	0.00594	CbGpPWpGaD
Phenprocoumon—ALB—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000257	0.00578	CbGpPWpGaD
Phenprocoumon—ALB—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000257	0.00578	CbGpPWpGaD
Phenprocoumon—CYP2C8—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00025	0.00564	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000241	0.00543	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000238	0.00535	CbGpPWpGaD
Phenprocoumon—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000226	0.00509	CbGpPWpGaD
Phenprocoumon—ALB—Folate Metabolism—SOD2—urinary bladder cancer	0.000209	0.0047	CbGpPWpGaD
Phenprocoumon—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000208	0.00467	CbGpPWpGaD
Phenprocoumon—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000204	0.00459	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000204	0.00458	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000201	0.00452	CbGpPWpGaD
Phenprocoumon—ALB—Folate Metabolism—GPX1—urinary bladder cancer	0.000199	0.00449	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—NAT2—urinary bladder cancer	0.000197	0.00444	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000194	0.00437	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000193	0.00434	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000193	0.00434	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00019	0.00429	CbGpPWpGaD
Phenprocoumon—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	0.000184	0.00414	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000176	0.00397	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000174	0.00392	CbGpPWpGaD
Phenprocoumon—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000166	0.00374	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.00016	0.00361	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000159	0.00358	CbGpPWpGaD
Phenprocoumon—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000158	0.00357	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000158	0.00356	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—HPGDS—urinary bladder cancer	0.000157	0.00355	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000157	0.00353	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—GSTT1—urinary bladder cancer	0.000153	0.00344	CbGpPWpGaD
Phenprocoumon—CYP2C8—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000147	0.00332	CbGpPWpGaD
Phenprocoumon—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000146	0.00329	CbGpPWpGaD
Phenprocoumon—VKORC1—Metabolism of proteins—IGF1—urinary bladder cancer	0.000141	0.00317	CbGpPWpGaD
Phenprocoumon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000137	0.00308	CbGpPWpGaD
Phenprocoumon—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000131	0.00294	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000128	0.00289	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000124	0.0028	CbGpPWpGaD
Phenprocoumon—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.000121	0.00273	CbGpPWpGaD
Phenprocoumon—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00012	0.0027	CbGpPWpGaD
Phenprocoumon—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000116	0.0026	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000114	0.00256	CbGpPWpGaD
Phenprocoumon—VKORC1—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000113	0.00255	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000113	0.00255	CbGpPWpGaD
Phenprocoumon—ALB—Folate Metabolism—IL2—urinary bladder cancer	0.000109	0.00245	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—GSTP1—urinary bladder cancer	0.000106	0.00238	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000106	0.00238	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000104	0.00235	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000104	0.00235	CbGpPWpGaD
Phenprocoumon—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	9.74e-05	0.00219	CbGpPWpGaD
Phenprocoumon—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	9.73e-05	0.00219	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.59e-05	0.00216	CbGpPWpGaD
Phenprocoumon—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	9.44e-05	0.00212	CbGpPWpGaD
Phenprocoumon—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	9.32e-05	0.0021	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.25e-05	0.00208	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	8.62e-05	0.00194	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.5e-05	0.00191	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	8.45e-05	0.0019	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	8.2e-05	0.00185	CbGpPWpGaD
Phenprocoumon—ALB—Folate Metabolism—TNF—urinary bladder cancer	7.92e-05	0.00178	CbGpPWpGaD
Phenprocoumon—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	7.92e-05	0.00178	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.81e-05	0.00176	CbGpPWpGaD
Phenprocoumon—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.69e-05	0.00173	CbGpPWpGaD
Phenprocoumon—ALB—Folate Metabolism—TP53—urinary bladder cancer	6.98e-05	0.00157	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	6.49e-05	0.00146	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—GSTZ1—urinary bladder cancer	6.45e-05	0.00145	CbGpPWpGaD
Phenprocoumon—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.29e-05	0.00142	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—NAT1—urinary bladder cancer	6.15e-05	0.00138	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	6.15e-05	0.00138	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—GSTO2—urinary bladder cancer	6.11e-05	0.00138	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—NAT1—urinary bladder cancer	6.11e-05	0.00138	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.05e-05	0.00136	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.01e-05	0.00135	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.68e-05	0.00128	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	5.62e-05	0.00127	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.6e-05	0.00126	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—UGT2B7—urinary bladder cancer	5.59e-05	0.00126	CbGpPWpGaD
Phenprocoumon—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	5.38e-05	0.00121	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	5.28e-05	0.00119	CbGpPWpGaD
Phenprocoumon—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.22e-05	0.00118	CbGpPWpGaD
Phenprocoumon—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.2e-05	0.00117	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.15e-05	0.00116	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	5.06e-05	0.00114	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—CYP4B1—urinary bladder cancer	5.03e-05	0.00113	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	5e-05	0.00113	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—NAT1—urinary bladder cancer	5e-05	0.00113	CbGpPWpGaD
Phenprocoumon—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	4.93e-05	0.00111	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.92e-05	0.00111	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—IFNA2—urinary bladder cancer	4.8e-05	0.00108	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	4.78e-05	0.00108	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—SLC19A1—urinary bladder cancer	4.75e-05	0.00107	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	4.66e-05	0.00105	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—PRSS3—urinary bladder cancer	4.63e-05	0.00104	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.58e-05	0.00103	CbGpPWpGaD
Phenprocoumon—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	4.14e-05	0.000931	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	4.12e-05	0.000928	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.89e-05	0.000876	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.79e-05	0.000854	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.74e-05	0.000841	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.72e-05	0.000839	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.71e-05	0.000836	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—TYMP—urinary bladder cancer	3.7e-05	0.000834	CbGpPWpGaD
Phenprocoumon—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	3.61e-05	0.000813	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.58e-05	0.000806	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.56e-05	0.000801	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.48e-05	0.000784	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—PLAU—urinary bladder cancer	3.41e-05	0.000767	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—NAT2—urinary bladder cancer	3.37e-05	0.000759	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—NAT2—urinary bladder cancer	3.35e-05	0.000754	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.3e-05	0.000743	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.3e-05	0.000743	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.04e-05	0.000685	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.03e-05	0.000683	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.02e-05	0.00068	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.91e-05	0.000656	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.91e-05	0.000655	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—RRM2—urinary bladder cancer	2.89e-05	0.000651	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—CREBBP—urinary bladder cancer	2.81e-05	0.000633	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—IGF1—urinary bladder cancer	2.77e-05	0.000625	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.74e-05	0.000617	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.72e-05	0.000612	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.69e-05	0.000606	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.69e-05	0.000606	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—HPGDS—urinary bladder cancer	2.68e-05	0.000603	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—ENO2—urinary bladder cancer	2.68e-05	0.000603	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.68e-05	0.000603	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.66e-05	0.000599	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.61e-05	0.000588	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—GSTT1—urinary bladder cancer	2.6e-05	0.000585	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.57e-05	0.000579	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.57e-05	0.000578	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.56e-05	0.000576	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—RHOA—urinary bladder cancer	2.54e-05	0.000572	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.5e-05	0.000563	CbGpPWpGaD
Phenprocoumon—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.43e-05	0.000548	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.37e-05	0.000533	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.19e-05	0.000494	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.19e-05	0.000494	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.18e-05	0.000491	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.17e-05	0.000489	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—NQO1—urinary bladder cancer	2.16e-05	0.000486	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—IL2—urinary bladder cancer	2.13e-05	0.00048	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.13e-05	0.000479	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.11e-05	0.000474	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.09e-05	0.000472	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.09e-05	0.000471	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2e-05	0.00045	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—EP300—urinary bladder cancer	1.91e-05	0.000431	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—SRC—urinary bladder cancer	1.86e-05	0.000419	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.84e-05	0.000414	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.83e-05	0.000411	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.81e-05	0.000408	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.81e-05	0.000407	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—GSTP1—urinary bladder cancer	1.8e-05	0.000405	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.77e-05	0.000398	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.75e-05	0.000394	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.74e-05	0.000392	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.71e-05	0.000386	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.68e-05	0.000379	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—TYMS—urinary bladder cancer	1.67e-05	0.000377	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.66e-05	0.000375	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.66e-05	0.000375	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—NCOR1—urinary bladder cancer	1.65e-05	0.000372	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—GSTM1—urinary bladder cancer	1.65e-05	0.000372	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.59e-05	0.000359	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—GPX1—urinary bladder cancer	1.58e-05	0.000357	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.56e-05	0.000352	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.56e-05	0.000351	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—ERCC2—urinary bladder cancer	1.56e-05	0.00035	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—KRAS—urinary bladder cancer	1.54e-05	0.000347	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.49e-05	0.000337	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.47e-05	0.000332	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.47e-05	0.000331	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—MTHFR—urinary bladder cancer	1.46e-05	0.000329	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.45e-05	0.000325	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.45e-05	0.000325	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.43e-05	0.000321	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.4e-05	0.000316	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.37e-05	0.000308	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—TP53—urinary bladder cancer	1.37e-05	0.000308	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.35e-05	0.000305	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.35e-05	0.000305	CbGpPWpGaD
Phenprocoumon—ALB—Hemostasis—HRAS—urinary bladder cancer	1.31e-05	0.000295	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000292	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.27e-05	0.000287	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000269	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.19e-05	0.000268	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—PPARG—urinary bladder cancer	1.19e-05	0.000267	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.17e-05	0.000262	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.15e-05	0.000258	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—CREBBP—urinary bladder cancer	1.14e-05	0.000256	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.72e-06	0.000219	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—PPARG—urinary bladder cancer	9.7e-06	0.000219	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	9.38e-06	0.000211	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—PTGS2—urinary bladder cancer	9.33e-06	0.00021	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	9.32e-06	0.00021	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.03e-06	0.000203	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.93e-06	0.000201	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.93e-06	0.000201	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.55e-06	0.000193	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.4e-06	0.000189	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—PTEN—urinary bladder cancer	8.18e-06	0.000184	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—PTEN—urinary bladder cancer	8.13e-06	0.000183	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.89e-06	0.000178	CbGpPWpGaD
Phenprocoumon—CYP2C8—Metabolism—EP300—urinary bladder cancer	7.8e-06	0.000176	CbGpPWpGaD
Phenprocoumon—ALB—Metabolism—EP300—urinary bladder cancer	7.76e-06	0.000175	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.63e-06	0.000172	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.66e-06	0.00015	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.4e-06	0.000144	CbGpPWpGaD
Phenprocoumon—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.35e-06	0.000143	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.15e-06	0.000138	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.03e-06	0.000113	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.39e-06	9.89e-05	CbGpPWpGaD
Phenprocoumon—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.19e-06	9.43e-05	CbGpPWpGaD
